Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Visual and Auditory Electromyography Biofeedback Among Stroke Patients

NCT: NCT07710937 · ACTIVE_NOT_RECRUITING

NCT IDNCT07710937
StatusACTIVE_NOT_RECRUITING
Start Date2026-04-09
Completion2026-10-12
SponsorUniversity of Lahore (OTHER)
First posted
Last updated

Brief Summary

Stroke commonly results in impairments of balance, mobility, and lower extremity motor function that limit independence in daily activities. Electromyography (EMG) biofeedback enhances motor relearning by providing real-time feedback regarding muscle activation. Although both visual and auditory EMG biofeedback have demonstrated benefits in stroke rehabilitation, evidence directly comparing these feedback modalities remains limited. This randomized controlled trial aims to compare the effects of visual and auditory EMG biofeedback, each combined with conventional physiotherapy, on balance, functional mobility, motor function, and functional independence in individuals with stroke.

Frequently Asked Questions

What is Visual and Auditory Electromyography Biofeedback Among Stroke Patients?

Visual and Auditory Electromyography Biofeedback Among Stroke Patients is a clinical trial registered under NCT07710937. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07710937?

The current status of NCT07710937 (Visual and Auditory Electromyography Biofeedback Among Stroke Patients) is: ACTIVE_NOT_RECRUITING.

When did Visual and Auditory Electromyography Biofeedback Among Stroke Patients start?

Visual and Auditory Electromyography Biofeedback Among Stroke Patients started on 2026-04-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.